Lokal Anestezik Toksisitesi: Olgu Sunumu

Authors

Mehmet Mutlu
https://orcid.org/0000-0002-9492-4321
Seray Türkmen

Synopsis

In the presented case report, surgery was scheduled for a 67-year-old patient under an axillary brachial plexus block due to a sharp object injury. For regional anesthesia, 10 mL of 0.5% bupivacaine and 10 mL of 2% prilocaine were administered. During the second intraoperative hour, following a decrease in the patient's SpO₂ level to 90%, arterial blood gas analysis revealed a methemoglobin level of 12.3%. Considering the possibility of Glucose-6-Phosphate dehydrogenase deficiency, 1 g of intravenous vitamin C was initially administered; however, as the methemoglobin level rose to 13.3%, 1 mg/kg of methylene blue was given. Following treatment, methemoglobin levels progressively decreased to 1.7% at the 24th hour, and the patient was safely transferred to the ward. Although local anesthetics are widely used, inadvertent intravascular injection, high doses, or altered absorption can cause central nervous system and cardiovascular toxicity. The central nervous system is more sensitive to local anesthetic toxicity than the cardiovascular system. In managing severe systemic toxicity, prompt oxygenation, ventilation, and intravenous 20% lipid emulsion therapy are vital. Additionally, the use of ultrasound guidance significantly lowers the risk of intravascular and intraneural injection.

References

El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives. Local Reg Anesth. 2018 Aug 8;11:35-44.

Wadlund DL. Local Anesthetic Systemic Toxicity. AORN J. 2017 Nov;106(5):367-377.

Gitman M, Fettiplace MR, Weinberg GL, et al. Local Anesthetic Systemic Toxicity: A Narrative Literature Review and Clinical Update on Prevention, Diagnosis, and Management. Plast Reconstr Surg. 2019 Sep;144(3):783-795.

Mulroy MF. Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures. Reg Anesth Pain Med. 2002 Nov-Dec;27(6):556-61.

Cocaine. Br Med J. 1979 Apr 14;1(6169):971-2..

Dickerson DM, Apfelbaum JL. Local anesthetic systemic toxicity. Aesthet Surg J. 2014 Sep;34(7):1111-9.

Drasner K. Local anesthetic systemic toxicity: a historical perspective. Reg Anesth Pain Med. 2010 Mar-Apr;35(2):162-6.

Moitra VK, Gabrielli A, Maccioli GA, O'Connor MF. Anesthesia advanced circulatory life support. Can J Anaesth. 2012 Jun;59(6):586-603.

Neal JM, Bernards CM, Butterworth JF 4th, Di Gregorio G, Drasner K, Hejtmanek MR, Mulroy MF, Rosenquist RW, Weinberg GL. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010 Mar-Apr;35(2):152-61.

Covino BG. Toxicity of local anesthetic agents. Acta Anaesthesiol Belg. 1988;39(3 Suppl 2):159-64.

Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.

Englesson S. The influence of acid-base changes on central nervous system toxicity of local anaesthetic agents. I. An experimental study in cats. Acta Anaesthesiol Scand. 1974;18(2):79-87.

Smith RB, Everett WG. Physiology and pharmacology of local anesthetic agents. Int Ophthalmol Clin. 1973 Summer;13(2):35-60.

Liu PL, Feldman HS, Giasi R, Patterson MK, Covino BG. Comparative CNS toxicity of lidocaine, etidocaine, bupivacaine, and tetracaine in awake dogs following rapid intravenous administration. Anesth Analg. 1983 Apr;62(4):375-9.

Bardsley H, Gristwood R, Baker H, et al. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol. 1998 Sep;46(3):245-9.

Pitkanen M, Feldman HS, Arthur GR, et al. Chronotropic and inotropic effects of ropivacaine, bupivacaine, and lidocaine in the spontaneously beating and electrically paced isolated, perfused rabbit heart. Reg Anesth. 1992 Jul-Aug;17(4):183-92.

Gristwood RW. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine. Drug Saf. 2002;25(3):153-63.

Leone S, Di Cianni S, Casati A, Fanelli G. Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine. Acta Biomed. 2008 Aug;79(2):92-105.

Mather LE, Chang DH. Cardiotoxicity with modern local anaesthetics: is there a safer choice? Drugs. 2001;61(3):333-42.

Butterworth JF 4th. Models and mechanisms of local anesthetic cardiac toxicity: a review. Reg Anesth Pain Med. 2010 Mar-Apr;35(2):167-76.

Bernards CM, Artru AA. Effect of intracerebroventricular picrotoxin and muscimol on intravenous bupivacaine toxicity. Evidence supporting central nervous system involvement in bupivacaine cardiovascular toxicity. Anesthesiology. 1993 May;78(5):902-10.

Mazoit JX, Decaux A, Bouaziz H, et al. Comparative ventricular electrophysiologic effect of racemic bupivacaine, levobupivacaine, and ropivacaine on the isolated rabbit heart. Anesthesiology. 2000 Sep;93(3):784-92.

Nath S, Häggmark S, Johansson G, et al. Differential depressant and electrophysiologic cardiotoxicity of local anesthetics: an experimental study with special reference to lidocaine and bupivacaine. Anesth Analg. 1986 Dec;65(12):1263-70.

Santos AC, Arthur GR, Wlody D, et al. Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes. Anesthesiology. 1995 Mar;82(3):734-40; discussion 27A.

Weinberg GL, VadeBoncouer T, Ramaraju GA, et al. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998 Apr;88(4):1071-5.

Weinberg G, Ripper R, Feinstein DL, et al. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003 May-Jun;28(3):198-202.

Rosenblatt MA, Abel M, Fischer GW, et al. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006 Jul;105(1):217-8.

Litz RJ, Popp M, Stehr SN, et al. Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion. Anaesthesia. 2006 Aug;61(8):800-1.

Collins-Nakai RL, Noseworthy D, Lopaschuk GD. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. Am J Physiol. 1994 Nov;267(5 Pt 2):H1862-71.

Hiller DB, Gregorio GD, Ripper R, et al. Epinephrine impairs lipid resuscitation from bupivacaine overdose: a threshold effect. Anesthesiology. 2009 Sep;111(3):498-505.

Weinberg GL, Di Gregorio G, Ripper R, et al. Resuscitation with lipid versus epinephrine in a rat model of bupivacaine overdose. Anesthesiology. 2008 May;108(5):907-13.

Di Gregorio G, Schwartz D, Ripper R, et al. Lipid emulsion is superior to vasopressin in a rodent model of resuscitation from toxin-induced cardiac arrest. Crit Care Med. 2009 Mar;37(3):993-9.

Neal JM. Ultrasound-guided regional anesthesia and patient safety: An evidence-based analysis. Reg Anesth Pain Med. 2010 Mar-Apr;35(2 Suppl):S59-67.

Published

January 13, 2022

License

License